Rapid increase in breast magnetic resonance imaging use trends from 2000 to 2011

JAMA Internal Medicine

Volumn 174, Issue 1, 2014, Pages 114-121

  Stout, Natasha K ^a   Nekhlyudov, Larissa ^a,b   Li, Lingling ^a   Malin, Elisabeth S ^c   Ross Degnan, Dennis ^a   Buist, Diana S M ^d   Rosenberg, Marjorie A ^e,f   Alfisher, Marina ^b   Fletcher, Suzanne W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Harvard Vanguard Medical Assoces ^*  (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER THERAPY; COHORT ANALYSIS; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; FAMILY HISTORY; FEMALE; GENE MUTATION; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MIDDLE AGED; NON PROFIT ORGANIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 84892423548     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.11958     Document Type: Article

References (42)

1. Harms SE, Flamig DP Breast MRI. Clin Imaging. 2001;25(4):227-246.
2. DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol. 2008;15(4):408-416.
3. Warner E, Messersmith H, Causer P., Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008;148(9):671-679.
4. Lord SJ, Lei W, Craft P., et al A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905-1917.
5. Bruening W, Uhl S, Fontanarosa J., Reston J, Treadwell J, Schoelles K. Noninvasive diagnostic tests for breast abnormalities: update of a 2006 review. Comparative Effectiveness Review No. 47. AHRQ Pub. No. 12-EHC014-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012. http://www.ncbi.nlm.nih. gov/books/NBK84530/. September 29, 2013.
6. Houssami N, Hayes DF Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59(5):290-302.
7. Brennan ME, Houssami N, Lord S., et al Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009;27(33):5640-5649.
8. Bigenwald RZ, Warner E, Gunasekara A., et al Is mammography adequate for screening women with inherited BRCA mutations and low breast density? Cancer Epidemiol Biomarkers Prev. 2008;17(3):706-711.
9. Griebsch I, Brown J, Boggis C., et al.; UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer. 2006;95(7): 801-810.
10. Plevritis SK, Kurian AW, Sigal B.M., et al Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295(20):2374-2384.
11. Saslow D, Boetes C, Burke W., et al.; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75-89.
12. Lehman CD, DeMartini W, Anderson B.O., Edge SB Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009;7(2):193-201.
13. Lee CH, Dershaw DD, Kopans D, et al Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18-27.
14. Hendrick RE, Cutter GR, Berns E.A., et al Community-based mammography practice: services, charges, and interpretation methods. AJR Am J Roentgenol. 2005;184(2):433-438.
15. Stout NK, Nekhlyudov L. Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. J Womens Health (Larchmt). 2011;20(4):631-634.
16. Bassett LW, Dhaliwal SG, Eradat J, et al National trends and practices in breast MRI. AJR Am J Roentgenol. 2008;191(2):332-339.
17. Sommer CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter W.R., Carey TS Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res. 2011;170(1):77-83.
18. Miller JW, Sabatino SA, Thompson T.D., et al Breast MRI use uncommon among US women. Cancer Epidemiol Biomarkers Prev. 2013;22(1):159-166.
19. Lobrano MB, Stolier A, L'Hoste R, Luttrell CA Breast MRI: patterns of utilization and impact on patient management in the community hospital setting. J La State Med Soc. 2012;164(1):38-42.
20. Kim HJ, Fay MP, Feuer E.J., Midthune DN Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351.
21. Ozanne EM, Drohan B, Bosinoff P., et al Which risk model to use? clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013;22(1):146-149.
22. US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143(5):355-361.
23. Port ER, Park A, Borgen P.I., Morris E., Montgomery LL Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol. 2007;14(3):1051-1057.
24. Yu J, Park A, Morris E., Liberman L, Borgen PI, King TA MRI screening in a clinic population with a family history of breast cancer. Ann Surg Oncol. 2008;15(2):452-461.
25. Deyo RA. Cascade effects of medical technology. Annu Rev Public Health. 2002;23(1):23-44.
26. Quinn EM, Coveney AP, Redmond HP Use of magnetic resonance imaging in detection of breast cancer recurrence: a systematic review. Ann Surg Oncol. 2012;19(9):3035-3041.
27. Khatcheressian JL, Wolff AC, Smith T.J., et al.; American Society of Clinical Oncology. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091-5097.
28. Lehman CD, Gatsonis C, Kuhl C.K., et al.; ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356(13):1295-1303.
29. Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011;378(9805):1804-1811.
30. Katipamula R, Degnim AC, Hoskin T, et al Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27(25):4082-4088.
31. Morrow M, Harris JR More mastectomies: is this what patients really want? J Clin Oncol. 2009;27(25):4038-4040.
32. Greenhalgh T, Robert G, Bate P., Macfarlane F, Kyriakidou O. Diffusion of Innovations of Health Service Organizations: A Systematic Literature Review. Malden: Blackwell; 2005.
33. Smith-Bindman R., Miglioretti DL, Johnson E, et al Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307(22):2400-2409.
34. Smith-Bindman R., Miglioretti DL, Larson EB Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood). 2008;27(6):1491-1502.
35. Mitchell JM. Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California. Med Care. 2008;46(5):460-466.
36. Dinan MA, Curtis LH, Hammill B.G., et al Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010;303(16):1625-1631.
37. Parker L, Levin DC, Frangos A, Rao VM Geographic variation in the utilization of noninvasive diagnostic imaging: national Medicare data, 1998-2007. AJR Am J Roentgenol. 2010;194(4):1034-1039.
38. Lee JM, Kopans DB, McMahon P.M., et al Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging - Markov Monte Carlo decision analysis. Radiology. 2008;246(3):763-771.
39. Heijnsdijk EA, Warner E, Gilbert F.J., et al Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening - MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev. 2012;21(9):1458-1468.
40. Passaperuma K, Warner E, Causer P.A., et al Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br J Cancer. 2012;107(1):24-30.
41. Djulbegovic B, Paul A. From efficacy to effectiveness in the face of uncertainty: indication creep and prevention creep. JAMA. 2011;305(19):2005- 2006.
42. Qaseem A, Alguire P, Dallas P., et al Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care. Ann Intern Med. 2012;156(2):147-149.